PharmGKB summary: citalopram pharmacokinetics pathway
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
aDepartments of Genetics bBioengineering, Stanford University, Stanford, California, USA Corresponding to Teri E. Klein, PhD, Department of Genetics, Stanford University Medical Center, 1501 California Ave, Stanford, CA 94304, USA Tel: +1 650 725 0659; fax: 650 725 3863; e-mail: [email protected]pharmgkb.org Received September 30, 2010 Accepted February 21, 2011
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Tatsumi, M., Groshan, K., Blakely, R. D., & Richelson, E. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01393-9 · Cited by 939
Pharmacogenetics Studies in STAR*D: Strengths, Limitations, and Results
Laje, G., Perlis, R. H., Rush, A. J., & McMahon, F. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1446 · Cited by 89
Cited by
PharmGKB: The Pharmacogenomics Knowledge Base
Thorn, C. F., Klein, T. E., & Altman, R. B. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-435-7_20 · Cited by 358
Self-citationImproving response inhibition systems in frontotemporal dementia with citalopram
Hughes, L. E., Rittman, T., Regenthal, R., Robbins, T. W., & Rowe, J. B. (2015) · Brain · doi:10.1093/brain/awv133 · Cited by 100
“Blood samples were taken 2 h after drug administration, immediately before the MEG recording, close to the estimated time of peak plasma concentration (Sangkuhl et al., 2011).”
MethodShelton, R. C., Parikh, S. V., Law, R. A., Rothschild, A. J., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Macaluso, M., et al. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113017 · Cited by 31
Rothschild, A. J., Parikh, S. V., Hain, D., Law, R., Thase, M. E., Dunlop, B. W., DeBattista, C., Conway, C. R., Forester, B. P., Shelton, R. C., et al. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2020.113649 · Cited by 20
Atomoxetine and citalopram alter brain network organization in Parkinson’s disease
Borchert, R. J., Rittman, T., Rae, C. L., Passamonti, L., Jones, S. P., Vatansever, D., Vázquez Rodríguez, P., Ye, Z., Nombela, C., Hughes, L. E., et al. (2019) · Brain Communications · doi:10.1093/braincomms/fcz013 · Cited by 14
Metadata
- Authors
- Sangkuhl, K., Klein, T. E., & Altman, R. B.
- Venue
- Pharmacogenetics and Genomics
- Published
- 2011-11
- Volume
- 21
- Issue
- 11
- Pages
- 769-772
- ISSN
- 1744-6872 (ISSN-L)
- OpenAlex
- W1976624390
- Cited by
- 85
- References
- 3
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PharmGKB summary: citalopram pharmacokinetics pathway. https://app.cochat.ai/papers/10.1097/fpc.0b013e328346063f
- The paper
- Sangkuhl, K., Klein, T. E., & Altman, R. B. (2011). PharmGKB summary: citalopram pharmacokinetics pathway. Pharmacogenetics and Genomics. https://doi.org/10.1097/fpc.0b013e328346063f
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.